{"id":616540,"title":"Notice: Revision of Guidance documents: Conduct and Analysis of Comparative Bioavailability Studies & Comparative Bioavailability Standards: Formulations used for Systemic Effects - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-02","captureTimestamp":"2026-03-02T21:36:49.526000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/comparative-bio-formulations-notice.html","snippet":"Notice: Revision of Guidance documents: Conduct and Analysis of Comparative Bioavailability Studies & Comparative Bioavailability Standards: Formulations used for Systemic Effects June 8, 2018 Our file number: 18-104623-884 Health Canada is pleased to announce the revision of two…","rawSnapshotUrl":"/api/snapshots/raw/616540","browseUrl":"https://replay.healtharchive.ca/job-6/20260302213649/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/comparative-bio-formulations-notice.html#ha_snapshot=616540","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}